AN insider-trading lawsuit is apparently being prepared against Eastman Kodak and its top execs relating to stock buys and a failed deal to finance a pharma venture during the pandemic, according to news reports. In a quarterly statement in a Security and Exchange Commission filing, Kodak stated that the case relates to Executive Chairman Jim Continenza’s purchase of 47,000 Kodak shares.
